Jones Financial Companies Lllp Boosts Stock Holdings in Colgate-Palmolive Company $CL

Jones Financial Companies Lllp grew its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 15.5% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 69,904 shares of the company’s stock after buying an additional 9,385 shares during the quarter. Jones Financial Companies Lllp’s holdings in Colgate-Palmolive were worth $5,566,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Westside Investment Management Inc. increased its stake in Colgate-Palmolive by 85.5% in the 2nd quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock worth $26,000 after purchasing an additional 130 shares during the period. Vermillion & White Wealth Management Group LLC grew its holdings in shares of Colgate-Palmolive by 86.1% in the second quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock worth $30,000 after purchasing an additional 155 shares during the last quarter. Copia Wealth Management bought a new position in shares of Colgate-Palmolive in the third quarter worth approximately $29,000. Cloud Capital Management LLC purchased a new position in shares of Colgate-Palmolive in the third quarter worth $30,000. Finally, MTM Investment Management LLC bought a new stake in Colgate-Palmolive during the 2nd quarter valued at $39,000. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Down 0.4%

NYSE:CL opened at $94.48 on Friday. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $100.18. The company has a debt-to-equity ratio of 5.90, a current ratio of 0.42 and a quick ratio of 0.27. The firm’s 50-day moving average price is $82.13 and its 200-day moving average price is $81.65. The company has a market capitalization of $76.16 billion, a PE ratio of 36.06, a P/E/G ratio of 4.29 and a beta of 0.29.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, January 30th. The company reported $0.95 earnings per share for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The business had revenue of $5.23 billion for the quarter, compared to analysts’ expectations of $5.13 billion. During the same quarter in the prior year, the company earned $0.91 earnings per share. The business’s revenue was up 5.8% compared to the same quarter last year. On average, equities analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Wednesday, January 21st will be paid a dividend of $0.52 per share. The ex-dividend date is Wednesday, January 21st. This represents a $2.08 dividend on an annualized basis and a yield of 2.2%. Colgate-Palmolive’s payout ratio is presently 79.39%.

Insider Buying and Selling

In other news, CFO Stanley J. Sutula III sold 97,843 shares of the stock in a transaction on Wednesday, February 4th. The stock was sold at an average price of $94.27, for a total value of $9,223,659.61. Following the sale, the chief financial officer directly owned 55,310 shares of the company’s stock, valued at approximately $5,214,073.70. This represents a 63.89% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 0.34% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the stock. Wells Fargo & Company boosted their price objective on shares of Colgate-Palmolive from $86.00 to $94.00 and gave the company an “equal weight” rating in a research report on Sunday, February 1st. Citigroup raised their target price on Colgate-Palmolive from $95.00 to $105.00 and gave the stock a “buy” rating in a research note on Monday. Evercore upped their price target on Colgate-Palmolive from $94.00 to $100.00 and gave the company an “outperform” rating in a research report on Monday, February 2nd. Piper Sandler lifted their price objective on Colgate-Palmolive from $88.00 to $96.00 and gave the stock an “overweight” rating in a research report on Friday, January 30th. Finally, UBS Group upped their target price on Colgate-Palmolive from $90.00 to $93.00 and gave the company a “buy” rating in a report on Wednesday, January 14th. Eleven equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and a consensus price target of $94.47.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.